Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The differences between claim-based health risk adjustment models and cost prediction models.

Guizhou Hu1, Erik Lesneski

  • 1BioSignia, Inc, Durham, North Carolina, USA. ghu@Biosignia.com

Disease Management : DM
|July 2, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening and identification of the H1R antagonists from natural products by BODIPY FL histamine recognition and DPHD-anchored bombardment coupled with target cell extraction.

Frontiers in pharmacology·2025
Same author

Exploration of material basis: Chemical composition profile, metabolic profile and pharmacokinetic characteristics in Xingbei Zhike granule.

Journal of ethnopharmacology·2023
Same author

Identification and quantification of cucurbitacin in watermelon frost using molecular networking integrated with ultra-high-performance liquid chromatography-tandem mass spectrometry.

Journal of separation science·2023
Same author

Rapidly and accurately screening histidine decarboxylase inhibitors from Radix Paeoniae alba using ultrafiltration-high performance liquid chromatography/mass spectrometry combined with enzyme channel blocking and directional enrichment technique.

Journal of chromatography. A·2023
Same author

Liquiritin inhibits MRGPRX2-mediated pseudo-allergy through the PI3K/AKT and PLCγ signaling pathways.

Heliyon·2023
Same author

An integrated strategy for the identification and screening of anti-allergy components from natural products based on calcium fluctuations and cell extraction coupled with HPLC-Q-TOF-MS.

Analytical and bioanalytical chemistry·2021
Same journal

Impact of behavioral adherence on clinical improvement and functional status in a diabetes disease management program.

Disease management : DM·2008
Same journal

Application of disease management principles to pregnancy and the postpartum period.

Disease management : DM·2008
Same journal

Co-occurring mental illness and health care utilization and expenditures in adults with obesity and chronic physical illness.

Disease management : DM·2008
Same journal

Disease management programs for the underserved.

Disease management : DM·2008
Same journal

Where we've gone wrong.

Disease management : DM·2008
Same journal

Weight loss and maintenance outcomes using moderate and severe caloric restriction in an outpatient setting.

Disease management : DM·2008
See all related articles

This study clarifies the distinctions between risk adjustment and cost prediction models, which are increasingly used with administrative claims data for healthcare management. Understanding these differences is crucial for accurate provider profiling and payment applications.

Area of Science:

  • Health Services Research
  • Healthcare Analytics
  • Biostatistics

Background:

  • Growing utilization of risk assessment tools with administrative claims data.
  • Applications include provider profiling, payment, underwriting, and disease/case management.
  • Existing tools are broadly categorized into risk adjustment and cost prediction models.

Purpose of the Study:

  • To elucidate the often-unrecognized differences between risk adjustment and cost prediction models.
  • To provide a clear distinction based on their core objectives and applications.
  • To compare the evaluation methodologies and accuracy assessments for both model types.

Main Methods:

  • Comparative analysis of risk adjustment and cost prediction models.
  • Examination of model objectives, including patient risk stratification versus future cost forecasting.

Related Experiment Videos

  • Review of distinct application domains and performance evaluation metrics for each model type.

    • Main Results:

    • Risk adjustment models focus on predicting healthcare costs based on patient characteristics for fairness in payment.
    • Cost prediction models aim to forecast future healthcare expenditures for resource allocation and budgeting.
    • Differences in evaluation metrics reflect their distinct purposes, impacting accuracy interpretation.

    Conclusions:

    • Clear differentiation between risk adjustment and cost prediction models is essential for appropriate application.
    • Misapplication can lead to inaccurate provider profiling, payment, and resource management.
    • Further research should focus on standardized evaluation frameworks tailored to each model type.